comparemela.com

புஜிஃபில்ம் செல்லுலார் இயக்கவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bayer s BlueRock Therapeutics widens cell therapy scope to the eye under new pact

BlueRock Therapeutics, a Bayer subsidiary, is teaming up with Opsis Therapeutics and Fujifilm Cellular Dynamics in an R&D pact focused on developing stem cell therapies for eye diseases. BlueRock is paying its new partners $30 million up front to kick off the alliance.

Global Cell Therapy Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2021-202

MarketsandResearch.biz has published a market research study on Global Cell Therapy Market Growth (Status and Outlook) 2021-2026 which aims to deliver a complete and in-detail study of the market using the primary or secondary resource and various research tools. The report maps the growth trajectory of the global Cell Therapy market by accurately evaluating all the vital factors that have a positive impact on the market growth. The report elaborately explains the fundamental reason behind the tremendous growth and development of the market. The market weakness, opportunities, strength, and risk analysis provide a holistic picture of the market growth and development. This market is expected to attain vigorous momentum in its growth during the forecast period from 2021 to 2026.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.